BIOMAT Database Logo BIOMAT Database Logo

[Clinical dosimetric analysis of the methods of radiation therapy in esophageal cancer]. 1978

A V Kozlova, and T K Dostanova, and M A Fadeeva, and L Ia Klepper, and I V Tarakanova

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011878 Radiotherapy The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions. Radiotherapy, Targeted,Targeted Radiotherapy,Radiation Therapy,Radiation Therapy, Targeted,Radiation Treatment,Targeted Radiation Therapy,Radiation Therapies,Radiation Therapies, Targeted,Radiation Treatments,Radiotherapies,Radiotherapies, Targeted,Targeted Radiation Therapies,Targeted Radiotherapies,Therapies, Radiation,Therapies, Targeted Radiation,Therapy, Radiation,Therapy, Targeted Radiation,Treatment, Radiation
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A V Kozlova, and T K Dostanova, and M A Fadeeva, and L Ia Klepper, and I V Tarakanova
Adaptive radiation therapy for cervical esophageal cancer: dosimetric and volumetric analysis.
June 2019, Journal of gastrointestinal oncology,
A V Kozlova, and T K Dostanova, and M A Fadeeva, and L Ia Klepper, and I V Tarakanova
[Clinical dosimetric aspects of the radiation therapy of endometrial cancer].
March 1980, Meditsinskaia radiologiia,
A V Kozlova, and T K Dostanova, and M A Fadeeva, and L Ia Klepper, and I V Tarakanova
A Multi-Institutional Analysis of Radiation Dosimetric Predictors of Toxicity After Trimodality Therapy for Esophageal Cancer.
January 2021, Practical radiation oncology,
A V Kozlova, and T K Dostanova, and M A Fadeeva, and L Ia Klepper, and I V Tarakanova
Clinical and dosimetric factors of radiation-induced esophageal injury: radiation-induced esophageal toxicity.
May 2005, World journal of gastroenterology,
A V Kozlova, and T K Dostanova, and M A Fadeeva, and L Ia Klepper, and I V Tarakanova
Clinical and dosimetric predictors of radiation-induced esophageal toxicity.
August 1999, International journal of radiation oncology, biology, physics,
A V Kozlova, and T K Dostanova, and M A Fadeeva, and L Ia Klepper, and I V Tarakanova
Dosimetric predictors of radiation-induced pericardial effusion in esophageal cancer.
July 2017, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
A V Kozlova, and T K Dostanova, and M A Fadeeva, and L Ia Klepper, and I V Tarakanova
Dosimetric and clinical predictors for radiation-induced esophageal injury.
February 2005, International journal of radiation oncology, biology, physics,
A V Kozlova, and T K Dostanova, and M A Fadeeva, and L Ia Klepper, and I V Tarakanova
[Clinical dosimetric prerequisites for improving the radiation therapy of skin cancer recurrences].
January 1979, Meditsinskaia radiologiia,
A V Kozlova, and T K Dostanova, and M A Fadeeva, and L Ia Klepper, and I V Tarakanova
Dosimetric Comparison of Radiation Therapy Using Hybrid-VMAT Technique for Stage I Esophageal Cancer.
April 2021, Anticancer research,
A V Kozlova, and T K Dostanova, and M A Fadeeva, and L Ia Klepper, and I V Tarakanova
Dosimetric Benefits of Midposition Compared With Internal Target Volume Strategy for Esophageal Cancer Radiation Therapy.
February 2019, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!